0000899243-22-018615.txt : 20220518
0000899243-22-018615.hdr.sgml : 20220518
20220518162758
ACCESSION NUMBER: 0000899243-22-018615
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220517
FILED AS OF DATE: 20220518
DATE AS OF CHANGE: 20220518
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HAYDEN DONALD J JR
CENTRAL INDEX KEY: 0001202285
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40869
FILM NUMBER: 22939494
MAIL ADDRESS:
STREET 1: C/O AMICUS THERAPEUTICS, INC.
STREET 2: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Theseus Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001745020
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 830712806
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 245 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (857) 400-9491
MAIL ADDRESS:
STREET 1: 245 MAIN STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-05-17
0
0001745020
Theseus Pharmaceuticals, Inc.
THRX
0001202285
HAYDEN DONALD J JR
C/O THESEUS PHARMACEUTICALS, INC.
314 MAIN STREET
CAMBRIDGE
MA
02142
1
0
0
0
Stock Option (right to buy)
8.02
2022-05-17
4
A
0
60000
0.00
A
2032-05-17
Common Stock
60000
60000
D
The options are subject to a service-based vesting requirement, which shall be satisfied over a three-year period with 1/36th of the options vesting on June 17, 2022 and 1/36th of the options vesting monthly thereafter, subject to the Reporting Person's continuous service with the issuer on each such vesting date.
/s/ Bradford Dahms - Attorney-in-Fact
2022-05-18